U.S. Gadolinium-based Contrast Media Market Size, Share & Trends Analysis Report By Type (Extracellular Agents, Blood Pool Agents, Hepatobiliary Agents), By Modality, By Indication, And Segment Forecasts, 2020 - 2027

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 Objectives
1.9.1 Objective - 1:
1.9.2 Objective - 2:
1.9.3 Objective - 3:
1.9.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 U.S. Gadolinium-Based Contrast Media Market: Variables, Trends, & Scope
3.1 Parent Market Outlook
3.2 Ancillary Market Outlook
3.3 Market Segmentation And Scope
3.4 Market Driver Analysis
3.4.1 Increase In The Prevalence Of Long-Term Diseases And Complex Comorbidities
3.4.2 Technological Advancements
3.4.3 Label Expansions
3.5 Market Restraint Analysis
3.5.1 Rising Concern About The Risk Of Gadolinium Retention In The Brain
3.6 Industry Challenges
3.7 Major Deals And Strategic Alliances Analysis
3.8 Market Entry Strategies
3.9 User Perspective Analysis
3.9.1 Consumer Behavior Analysis
3.9.2 Market Influencer Analysis
3.9.3 List Of Key End Users
3.10 Regulatory Framework
3.11报销框架
3.12 Standards & Compliances
3.13 Penetration & Growth Prospect Mapping
3.14 Porter’s Five Forces Analysis
3.15 PESTEL Analysis
Chapter 4 The U.S. Gadolinium-Based Contrast Media Market: Type Segment Analysis
4.1 The U.S. Gadolinium -Based Contrast Media: Type Market Share Analysis, 2019 & 2027
4.2 Extracellular Agents
4.2.1 Extracellular Agents Market, 2016 - 2027 (USD Million)
4.3 Blood Pool Agents
4.3.1 Blood Pool Agentsmarket, 2016 - 2027 (USD Million)
4.4肝胆的年龄nts
4.4.1 Hepatobiliary Agents Market, 2016 - 2027 (USD Million)
Chapter 5 The U.S. Gadolinium-Based Contrast Media Market: Modality Segment Analysis
5.1 The U.S. Gadolinium-Based Contrast Media: Market Share Analysis, 2019 & 2027
5.2核磁共振成像(MRI)
5.2.1 MRI Market, 2016 - 2027 (USD Million)
5.3 Magnetic Resonance Angiography (MRA)
5.3.1 MRA Market, 2016 - 2027 (USD Million)
Chapter 6 U.S. Gadolinium-based Contrast Media Market: Indication Segment Analysis
6.1 The U.S. Gadolinium-based Contrast Media: Market Share Analysis, 2018 & 2027
6.2 Cardiovascular
6.2.1 Cardiovascular Market, 2016 - 2027 (USD Million)
6.3 Cancer
6.3.1 Cancer Market, 2016 - 2027 (USD Million)
6.4 Neurology
6.4.1 Neurology Market, 2016 - 2027 (USD Million)
6.5 Others
6.5.1 Others Market, 2016 - 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.1.1 Bayer AG
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 GE HEALTHCARE
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Guerbet
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Lantheus Medical Imaging, Inc
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Bracco Diagnostic Inc.
7.1.5.1 Company overview
7.1.5.2 Product benchmarking
7.1.5.3 Strategic initiatives
7.1.6 Trivitron Healthcare
7.1.6.1 Company overview
7.1.6.2连续ct benchmarking

List of Tables

Table 1 List of secondary sources

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 The U.S. gadolinium-based contrast media market snapshot (2019)
Fig. 11 The U.S. gadolinium-based contrast media market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 The U.S. gadolinium-based contrast media market Type outlook: Segment dashboard
Fig. 18 The U.S. gadolinium-based contrast media market: Type movement analysis
Fig. 19 Extracellular agents market, 2016 - 2027 (USD Million)
Fig. 20 Blood pool agents market, 2016 - 2027 (USD Million)
Fig. 21 Hepatobiliary agents market, 2016 - 2027 (USD Million)
Fig. 22 The U.S. gadolinium-based contrast media market modality outlook: Segment dashboard
Fig. 23 The U.S. gadolinium-based contrast media market: modality movement analysis
Fig. 24 MRI market, 2016 - 2027 (USD Million)
Fig. 25 MRA market, 2016 - 2027 (USD Million)
Fig. 26 The U.S. gadolinium-based contrast media market indication outlook: Segment dashboard
Fig. 27 The U.S. gadolinium-based contrast media market: indication movement analysis
Fig. 28 Cardiovascular conditions market, 2016 - 2027 (USD Million)
Fig. 29 Cancer market, 2016 - 2027 (USD Million)
图30神经市场,2016 - 2027(百万美元)
Fig. 31 Others market, 2016 - 2027 (USD Million)